Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00453557 · ClinicalTrials.gov registry record · Phase 4
Mechanism of Growth Hormone Effects on Adipose Tissue
A Phase 4 study, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT00453557 is a Phase 4 study that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 30 participants.
The verdict
NCT00453557, a Phase 4 study, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
Growth hormone treatment in humans has been shown to decrease body fat. This study aims to determine what adipose tissue depots are affected by GH and what is the mechanism.
Interventions
- DRUG rhGH
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 1999-04 |
| Est. Completion | 2000-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00453557
The ClinicalTrials.gov registry entry for NCT00453557 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which rhGH is the first listed.
NCT00453557 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00453557 about?
NCT00453557 is a clinical study titled "Mechanism of Growth Hormone Effects on Adipose Tissue". Growth hormone treatment in humans has been shown to decrease body fat. This study aims to determine what adipose tissue depots are affected by GH and what is the mechanism.
What is the current status of trial NCT00453557?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 1999-04. Estimated completion is 2000-12.
What interventions are being tested in trial NCT00453557?
The interventions under investigation include: rhGH (DRUG).
Who is sponsoring clinical trial NCT00453557?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.